How did US search behavior around hair loss treatment change over the first half of 2026? Based on Google search-interest data, the conversation is moving from topical lotions toward pills, women are driving the fastest growth in treatment interest, and people are increasingly searching for where to obtain treatment near them. This report walks through five shifts in the data, leads with the numbers, names no commercial brands, and makes no claim about any single product's effectiveness.
Methodology, in plain terms
The figures below come from US Google search-interest exports covering two windows ending June 20, 2026: a 24-hour snapshot and a rolling three-month window. Search-interest values are relative indices (a query's popularity scaled against the peak in the set), not absolute search counts, and the percentages are period-over-period changes in that relative interest. Short windows and relative scaling mean these numbers describe direction and momentum, not market size. Where the raw data named specific commercial products, we have grouped them into neutral categories (for example, "branded minoxidil products" rather than any trademark).
1. The pill pivot: oral minoxidil is the fastest-rising treatment query
The single clearest movement in the data is the shift in interest from topical minoxidil toward the oral, low-dose tablet form that dermatologists have increasingly prescribed off-label over the past few years.
- Searches for low-dose minoxidil tablets (the 2.5 mg strength specifically) rose roughly 400% over the three-month window.
- General "minoxidil tablets" interest rose about 120%.
- Interest in the oral form broadly continued to climb while several topical-specific queries grew more slowly.
This tracks a real clinical story: low-dose oral minoxidil has moved from a niche option to a mainstream one in dermatology, and consumer search behavior is now catching up to the prescribing trend. It is worth stressing that oral minoxidil for hair loss is used off-label and is a prescription decision that requires medical screening, particularly around cardiovascular factors. The search surge reflects curiosity, not suitability.
2. Women are driving the fastest growth in treatment interest
When the data is split by audience, the growth in women's interest outpaced men's, despite hair loss still being more culturally associated with men.
- "Women's hair loss treatment" interest rose roughly 850% over the three-month window.
- "Men's hair loss treatment" rose roughly 750% over the same window.
Both are large increases, but the female-oriented queries grew faster. This is consistent with a broader cultural shift toward women discussing and seeking treatment for thinning hair, a topic that has historically carried more stigma and less open conversation than male pattern hair loss.
3. People want treatment nearby and now
A cluster of queries signals that searchers are not just researching, they are trying to act, and to act locally.
- "Hair loss treatment near me" interest rose about 30% over three months, and a comparable retail-pharmacy query rose roughly 250%.
- "Minoxidil near me" rose about 90%.
The "near me" and pharmacy-specific growth suggests rising intent to obtain treatment quickly rather than to deliberate indefinitely. It also points to a consumer expectation of convenience and access that telehealth and retail channels are both competing to meet.
4. Format experimentation: foams, sprays, and medicated shampoos
Beyond the pill, searchers are increasingly curious about which delivery format suits them.
- Foam formulations of topical minoxidil rose between roughly 60% and 190% depending on the exact phrasing, with the 5% foam among the faster movers.
- Medicated and ingredient-specific shampoo queries rose sharply, with one antifungal shampoo term up about 250% and general treatment-shampoo interest up about 70%.
The pattern suggests people are looking for a format that fits their routine and tolerability, not just an active ingredient. Formulation matters to real users: the carrier in a topical, for instance, is a common driver of scalp irritation, which is part of why foam interest tends to rise among people who found a liquid uncomfortable.
5. The DHT-blocker conversation is broadening
Interest in the oral DHT-pathway category continued to grow, and a newer topical version of that category drew notable attention.
- The leading oral DHT-blocker term rose about 80% over three months.
- Interest in a topical version of that medication rose roughly 150%, a sign that searchers are looking for the benefits of the category with a potentially different side-effect profile.
This mirrors a wider theme across the dataset: people are not just asking "what works," they are asking "what works with the fewest trade-offs for me," whether that means a pill instead of a daily lotion, a foam instead of a liquid, or a topical instead of an oral.
What it adds up to
Across all five shifts, the throughline is agency. The 2026 hair-loss searcher is comparing routes of administration, weighing side-effect profiles, looking for local and fast access, and increasingly likely to be a woman. The market conversation has matured from "is there anything I can do" to "which specific option fits my body and my routine."
For anyone covering this space, the most newsworthy single data point is the oral-tablet surge, because it shows consumer awareness catching up to a genuine and relatively recent change in how clinicians treat pattern hair loss. The most under-told story is the speed of growth in women's interest.
About this data
Prepared by the Curekey team from US Google search-interest exports for the period ending June 20, 2026. Figures are relative-interest changes, not absolute search volumes. Curekey is a telehealth platform for hair loss; this report is editorial and references no patient data. Medical decisions about any treatment, including which medication and which form, should be made with a licensed clinician.
Related reading
- Oral vs. topical minoxidil: the two routes of administration behind the pill-pivot trend, and how they compare.
- Minoxidil foam vs. liquid: the formulation question behind the foam and format experimentation trend.
- What DHT is and why it causes pattern hair loss: the hormonal pathway behind the DHT-blocker category.
- Androgenetic alopecia: the clinical condition most of these treatments are used for.
- New hair loss treatments in research: where the next wave of options is coming from.
- How it works: what a Curekey assessment and physician review involve.
